Yoshiaki Oda

Nihon Medi-Physics Co., Ltd. is a leading manufacturer of radiopharmaceuticals, based in Japan. The Japanese company is engaged in ensuring stable supply and research and development of new products. It is also working on research and development of "theranostics," a novel medical technology to provide optimal medical service to each patient, as well as on the dissemination of nuclear medicine in Asian countries by licensing its products. Nihon Medi-Physics Co. was founded in 1973, and the CEO is Nobuhiko Tamura.

Part of Sumitomo Chemical Co., Ltd., Sumika Chemical Analysis Service Ltd. was founded in 1972 and is a general analysis company based in Osaka, Japan. The Japanese company provides registration application services for chemical regulations and application support services necessary for manufacturing, selling, and exporting pharmaceuticals and medical equipment. The private company strategically consults necessary exams during the registration process and offer evaluation and analysis of various raw materials and products, environmental surveys, risk management support, and consultancy services for research and development, application, manufacturing, and sales of pharmaceuticals.

Part of Sumitomo Chemical Co., Ltd., Sumika Chemical Analysis Service Ltd. was founded in 1972 and is a general analysis company based in Osaka, Japan. The Japanese company provides registration application services for chemical regulations and application support services necessary for manufacturing, selling, and exporting pharmaceuticals and medical equipment. The private company strategically consults necessary exams during the registration process and offer evaluation and analysis of various raw materials and products, environmental surveys, risk management support, and consultancy services for research and development, application, manufacturing, and sales of pharmaceuticals.

Part of Sumitomo Chemical Co., Ltd., Sumika Chemical Analysis Service Ltd. was founded in 1972 and is a general analysis company based in Osaka, Japan. The Japanese company provides registration application services for chemical regulations and application support services necessary for manufacturing, selling, and exporting pharmaceuticals and medical equipment. The private company strategically consults necessary exams during the registration process and offer evaluation and analysis of various raw materials and products, environmental surveys, risk management support, and consultancy services for research and development, application, manufacturing, and sales of pharmaceuticals.

Nihon Medi-Physics Co., Ltd. is a leading manufacturer of radiopharmaceuticals, based in Japan. The Japanese company is engaged in ensuring stable supply and research and development of new products. It is also working on research and development of "theranostics," a novel medical technology to provide optimal medical service to each patient, as well as on the dissemination of nuclear medicine in Asian countries by licensing its products. Nihon Medi-Physics Co. was founded in 1973, and the CEO is Nobuhiko Tamura.

BONAC Corp. develops diagnostic drugs based on nucleic acid chemistry. The company was founded in February 2010 and is headquartered in Kurume, Japan.

BONAC Corp. develops diagnostic drugs based on nucleic acid chemistry. The company was founded in February 2010 and is headquartered in Kurume, Japan.

Nihon Medi-Physics Co., Ltd. is a leading manufacturer of radiopharmaceuticals, based in Japan. The Japanese company is engaged in ensuring stable supply and research and development of new products. It is also working on research and development of "theranostics," a novel medical technology to provide optimal medical service to each patient, as well as on the dissemination of nuclear medicine in Asian countries by licensing its products. Nihon Medi-Physics Co. was founded in 1973, and the CEO is Nobuhiko Tamura.

Part of Sumitomo Chemical Co., Ltd., Sumika Chemical Analysis Service Ltd. was founded in 1972 and is a general analysis company based in Osaka, Japan. The Japanese company provides registration application services for chemical regulations and application support services necessary for manufacturing, selling, and exporting pharmaceuticals and medical equipment. The private company strategically consults necessary exams during the registration process and offer evaluation and analysis of various raw materials and products, environmental surveys, risk management support, and consultancy services for research and development, application, manufacturing, and sales of pharmaceuticals.

Nihon Medi-Physics Co., Ltd. is a leading manufacturer of radiopharmaceuticals, based in Japan. The Japanese company is engaged in ensuring stable supply and research and development of new products. It is also working on research and development of "theranostics," a novel medical technology to provide optimal medical service to each patient, as well as on the dissemination of nuclear medicine in Asian countries by licensing its products. Nihon Medi-Physics Co. was founded in 1973, and the CEO is Nobuhiko Tamura.

Nihon Medi-Physics Co., Ltd. is a leading manufacturer of radiopharmaceuticals, based in Japan. The Japanese company is engaged in ensuring stable supply and research and development of new products. It is also working on research and development of "theranostics," a novel medical technology to provide optimal medical service to each patient, as well as on the dissemination of nuclear medicine in Asian countries by licensing its products. Nihon Medi-Physics Co. was founded in 1973, and the CEO is Nobuhiko Tamura.

Nihon Medi-Physics Co., Ltd. is a leading manufacturer of radiopharmaceuticals, based in Japan. The Japanese company is engaged in ensuring stable supply and research and development of new products. It is also working on research and development of "theranostics," a novel medical technology to provide optimal medical service to each patient, as well as on the dissemination of nuclear medicine in Asian countries by licensing its products. Nihon Medi-Physics Co. was founded in 1973, and the CEO is Nobuhiko Tamura.

BONAC Corp. develops diagnostic drugs based on nucleic acid chemistry. The company was founded in February 2010 and is headquartered in Kurume, Japan.

BONAC Corp. develops diagnostic drugs based on nucleic acid chemistry. The company was founded in February 2010 and is headquartered in Kurume, Japan.

Part of Sumitomo Chemical Co., Ltd., CDT Holdings Ltd. provides professional, scientific and technical services. The private company is based in Godmanchester, UK.

BONAC Corp. develops diagnostic drugs based on nucleic acid chemistry. The company was founded in February 2010 and is headquartered in Kurume, Japan.

Part of Sumitomo Chemical Co., Ltd., CDT Holdings Ltd. provides professional, scientific and technical services. The private company is based in Godmanchester, UK.

BONAC Corp. develops diagnostic drugs based on nucleic acid chemistry. The company was founded in February 2010 and is headquartered in Kurume, Japan.

Part of Sumitomo Chemical Co., Ltd., Sumika Chemical Analysis Service Ltd. was founded in 1972 and is a general analysis company based in Osaka, Japan. The Japanese company provides registration application services for chemical regulations and application support services necessary for manufacturing, selling, and exporting pharmaceuticals and medical equipment. The private company strategically consults necessary exams during the registration process and offer evaluation and analysis of various raw materials and products, environmental surveys, risk management support, and consultancy services for research and development, application, manufacturing, and sales of pharmaceuticals.